Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • "Best of" Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Prevention Research
Cancer Prevention Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • "Best of" Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Research Article

Cucurbitacin B Alters the Expression of Tumor-Related Genes by Epigenetic Modifications in NSCLC and Inhibits NNK-Induced Lung Tumorigenesis

Samriddhi Shukla, Sajid Khan, Sudhir Kumar, Sonam Sinha, Mohd. Farhan, Himangsu K. Bora, Rakesh Maurya and Syed Musthapa Meeran
Samriddhi Shukla
1Laboratory of Cancer Epigenetics, Division of Endocrinology, CSIR-Central Drug Research Institute, Lucknow, India.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sajid Khan
1Laboratory of Cancer Epigenetics, Division of Endocrinology, CSIR-Central Drug Research Institute, Lucknow, India.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sudhir Kumar
2Division of Medicinal and Process Chemistry, CSIR-Central Drug Research Institute, Lucknow, India.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sonam Sinha
1Laboratory of Cancer Epigenetics, Division of Endocrinology, CSIR-Central Drug Research Institute, Lucknow, India.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohd. Farhan
1Laboratory of Cancer Epigenetics, Division of Endocrinology, CSIR-Central Drug Research Institute, Lucknow, India.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Himangsu K. Bora
3Division of Laboratory Animals, CSIR-Central Drug Research Institute, Lucknow, India.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rakesh Maurya
2Division of Medicinal and Process Chemistry, CSIR-Central Drug Research Institute, Lucknow, India.
4Academy of Scientific and Innovative Research (AcSIR), New Delhi, India.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Syed Musthapa Meeran
1Laboratory of Cancer Epigenetics, Division of Endocrinology, CSIR-Central Drug Research Institute, Lucknow, India.
4Academy of Scientific and Innovative Research (AcSIR), New Delhi, India.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: s.musthapa@cdri.res.in
DOI: 10.1158/1940-6207.CAPR-14-0286 Published June 2015
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Additional Files
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    CuB inhibits cellular proliferation and induces apoptosis as well as alters the expression of key tumor-related genes in human NSCLC cells. A, IC50 values of CuB (0.01–40 μmol/L)-treated NSCLC cells at 24, 48, and 72 hours. B, treatment with CuB at indicated doses for 48 hours induced cellular apoptosis in H1299 cells. The graphical representation shows the percentage of total apoptotic cells. C, CuB-induced G2–M phase cell-cycle arrest in H1299 cells at 48 hours. The values are mean ± SE of cells in G2–M phase. D and E, effect of CuB treatment (0–860 nmol/L) on the mRNA and protein expressions of p16INK4A, p21CIP1/WAF1, c-MYC, and K-RAS at 48 hours in H1299 cells. F, effect of CuB treatment on the mRNA expressions of hTERT at 48 hours. The values were plotted as relative fold mRNA expression and were normalized to GAPDH. The protein expressions at similar treatment conditions are shown under respective real-time mRNA expression results with β-actin as an equal loading control. Results represent mean of 3 independent experiments (mean ± SE). Significance against respective control. *, P < 0.05.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    CuB inhibits epigenetic modulatory enzymes. A, effect of CuB treatment on the mRNA expressions of DNMTs in H1299 cells after 48 hours. The values are normalized to GAPDH. B, treatment of H1299 cells with CuB for 48 hours altered the levels of protein expression of DNMTs. Graphical representations are indicative of relative band intensities. C, effect of CuB treatment on the protein expressions of HDACs, SIRTs, and HATs at 48 hours in H1299 cells. β-Actin was used as an equal loading control. D, H1299 cells were treated with indicated concentrations of CuB for 48 hours and nuclear extracts were assessed for HDACs activity. The values are mean ± SE. *, P < 0.05 against respective control.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    CuB induced histone modification changes at the p16INK4A promoter. A, schematic representation of different CpG-rich regions (represented as ChIP 1–5) of the p16INK4A promoter, upstream of the transcription start site. B, H1299 cells were treated with the indicated concentrations of CuB for 48 hours and analyzed by ChIP-PCR assays for the enrichment of different chromatin markers at the p16INK4A promoter. Input DNA was used as control. IgG control was used as negative control. The gel images are representatives of 3 independent experiments. C, The x-axes represent CuB concentrations in nmol/L, and the y-axes represent the relative enrichment of individual histone modifications and binding factors, the percentage of untreated immunoprecipitates compared with the corresponding input samples (defined as 1) at different primer positions. Each point indicates the mean ± SE. *, P < 0.05 against respective control.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    CuB induced histone modification changes at the p21CIP1/WAF1 promoter. A, schematic representation of amplicons for 2 different CpG-rich regions (represented as ChIP1 and ChIP2) of the p21CIP1/WAF1 promoter. B, H1299 cells were treated with the indicated concentrations of CuB for 48 hours and analyzed by ChIP-PCR for the enrichment of different chromatin markers at the p21CIP1/WAF1 promoter. Input DNA was used as control. IgG control was used as a negative control. The gel images are representatives of 3 independent experiments. C, the x-axes represent CuB concentrations in nmol/L, and the y-axes represent the relative enrichment of individual binding factors. Each point indicates the mean ± SE. *, P < 0.05 against respective control.

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5.

    CuB alters the enrichment of different histone modification marks at the hTERT promoter. A, schematic representation of amplicon for different CpG-rich regions (represented as ChIP 1–5) of the hTERT promoter, spanning from distal promoter to the first exonic region. B, H1299 cells were treated with the indicated concentrations of CuB for 48 hours and analyzed for the binding of various chromatin marks and transcriptional factors in the promoter region of hTERT. Input DNA samples were used as control. IgG control was used as a negative control. The gel images are representatives of 3 independent experiments. C, the x-axes represent CuB concentrations in nmol/L, and the y-axes represent the relative enrichment of individual binding factors compared with the corresponding input samples (defined as 1). Each point indicates the mean ± SE. *, P < 0.05 against respective control.

  • Figure 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 6.

    CuB inhibited NNK-induced lung tumorigenesis in A/J mice. A, schematic representation of the experimental protocol used to study the effects of CuB on NNK-induced lung carcinogenesis in A/J mice. B, representative lung histology (10× and 20×) of different animal groups using H&E staining. The arrows represent angiogenesis; circles represent microadenomas; and squares represent tumor hyperplasia. C, the percentages of tumor incidence and tumor multiplicity of indicated animal groups are plotted. Columns, mean (n = 8); bars, SD. D, percentage of PCNA- and TUNEL-positive cells in the lung sections of different animal groups. Columns, mean (n = 8); bars, SD. *, P < 0.05; **, P < 0.01, significant against the NNK-induced control group. E, effect of CuB treatment on the protein expressions of different DNMTs and HDACs in mouse lung tissue. β-Actin was used as an equal loading control. The blots are representative of 3 independent experiments. F, effect of CuB treatment on the mRNA expressions of p16INK4A, p21CIP1/WAF1, and Tert as well as protein expressions of c-MYC and RAS in the mouse lung tissue. For mRNA expressions, the values were plotted as relative fold mRNA expression and were normalized to Gapdh. The results are means ± SE. *, P < 0.05, significant against the vehicle-treated control group.

Additional Files

  • Figures
  • Supplementary Data

    Files in this Data Supplement:

    • Supplementary Tables S1-4 - Supplementary Tables S1-4. The isolation and spectral data of CuB, list of Primers used for qRT-PCR, MSP, ChIP analysis and histopathological grading of CuB-treated NNK-induced lung tumors
    • Supplementary Fig S1 - Supplementary Fig S1. Anti-proliferative and pro-apoptotic effects of CuB against different NSCLC cells
    • Supplementary Fig S2 - Supplementary Fig S2. CuB alters the global as well as gene-specific pattern of methylation in H1299 cells
    • Supplementary Fig S3 - Supplementary Fig S3. Average body weights and representative lung histology of different animal groups
    • Supplementary Figure legends - Supplementary Figure legends. Supplementary Figure S1-S3 legends
PreviousNext
Back to top
Cancer Prevention Research: 8 (6)
June 2015
Volume 8, Issue 6
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Prevention Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Cucurbitacin B Alters the Expression of Tumor-Related Genes by Epigenetic Modifications in NSCLC and Inhibits NNK-Induced Lung Tumorigenesis
(Your Name) has forwarded a page to you from Cancer Prevention Research
(Your Name) thought you would be interested in this article in Cancer Prevention Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Cucurbitacin B Alters the Expression of Tumor-Related Genes by Epigenetic Modifications in NSCLC and Inhibits NNK-Induced Lung Tumorigenesis
Samriddhi Shukla, Sajid Khan, Sudhir Kumar, Sonam Sinha, Mohd. Farhan, Himangsu K. Bora, Rakesh Maurya and Syed Musthapa Meeran
Cancer Prev Res June 1 2015 (8) (6) 552-562; DOI: 10.1158/1940-6207.CAPR-14-0286

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Cucurbitacin B Alters the Expression of Tumor-Related Genes by Epigenetic Modifications in NSCLC and Inhibits NNK-Induced Lung Tumorigenesis
Samriddhi Shukla, Sajid Khan, Sudhir Kumar, Sonam Sinha, Mohd. Farhan, Himangsu K. Bora, Rakesh Maurya and Syed Musthapa Meeran
Cancer Prev Res June 1 2015 (8) (6) 552-562; DOI: 10.1158/1940-6207.CAPR-14-0286
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosure of Potential Conflicts of Interest
    • Authors' Contributions
    • Grant Support
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Breast Cancer Genetic Risk and Endocrine Therapy Acceptance
  • Obesity and Telomere Length in Prostate Stromal Cells
  • Regulatory T Cells and Melanocytic Nevi
Show more Research Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Prevention Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Prevention Research
eISSN: 1940-6215
ISSN: 1940-6207

Advertisement